Back to Search
Start Over
Sangamo Enters License Pact with Genentech
- Source :
- Wireless News. August 19, 2024
- Publication Year :
- 2024
-
Abstract
- Sangamo Therapeutics, a genomic medicine company, reported it has entered into a license agreement with Genentech, a member of the Roche Group, to develop intravenously administered genomic medicines to treat [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Wireless News
- Publication Type :
- News
- Accession number :
- edsgcl.805373773